A Phase 1 Study of Single Agent Veliparib in Japanese Subjects With Advanced Solid Tumors
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Advanced Solid Tumors
Interventions: DRUG: veliparib (ABT-888)
Sponsor: AbbVie